VNDA
Vanda Pharmaceuticals Inc. Healthcare - Biotechnology Investor Relations →
Vanda Pharmaceuticals Inc. (VNDA) closed at $7.57 as of 2026-02-02, trading 23.0% above its 200-week moving average of $6.15. The stock moved further from the line this week, up from 22.1% last week. With a 14-week RSI of 76, VNDA is in overbought territory.
Over the past 986 weeks of data, VNDA has crossed below its 200-week moving average 17 times. On average, these episodes lasted 33 weeks. The average one-year return after crossing below was -17.5%, suggesting these dips have not historically been reliable buying opportunities for this stock.
With a market cap of $447 million, VNDA is a small-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at -16.7%. The stock trades at 1.0x book value.
Share count has increased 4.3% over three years, indicating dilution.
Over the past 19 years, a hypothetical investment of $100 in VNDA would have grown to $31, compared to $692 for the S&P 500. VNDA has returned -6.0% annualized vs 10.7% for the index, underperforming the broader market over this period.
Free cash flow has been declining at a -100% compound annual rate. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Growth of $100: VNDA vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After VNDA Crosses Below the Line?
Across 17 historical episodes, buying VNDA when it crossed below its 200-week moving average produced an average return of -22.2% after 12 months (median -25.0%), compared to +4.9% for the S&P 500 over the same periods. 18% of those episodes were profitable after one year. After 24 months, the average return was -11.9% vs +19.6% for the index.
Each line shows $100 invested at the moment VNDA crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
VNDA has crossed below its 200-week MA 17 times with an average 1-year return of +-17.5% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Jul 2007 | Oct 2007 | 10 | 15.9% | -93.9% | -53.5% |
| Oct 2007 | May 2009 | 81 | 95.2% | -94.7% | -51.8% |
| Oct 2009 | Nov 2009 | 1 | 0.1% | -28.3% | -25.8% |
| Jan 2010 | Feb 2010 | 1 | 2.3% | -20.0% | -24.4% |
| Apr 2010 | Dec 2010 | 34 | 38.0% | -4.2% | -9.9% |
| Jan 2011 | Apr 2011 | 13 | 11.7% | -36.0% | -6.0% |
| May 2011 | Jun 2011 | 7 | 5.1% | -41.0% | +3.6% |
| Aug 2011 | May 2013 | 94 | 56.5% | -40.7% | +12.1% |
| Nov 2013 | Nov 2013 | 1 | 6.0% | +88.9% | +21.3% |
| Nov 2015 | Dec 2015 | 2 | 6.4% | +74.1% | -15.5% |
| Jan 2016 | May 2016 | 20 | 19.2% | +87.0% | -7.8% |
| May 2019 | Nov 2019 | 27 | 20.0% | -25.0% | -50.5% |
| Dec 2019 | Feb 2021 | 58 | 48.7% | -18.2% | -52.9% |
| Mar 2021 | Apr 2021 | 2 | 3.0% | -25.9% | -51.1% |
| Aug 2021 | Aug 2021 | 3 | 2.0% | -34.1% | -52.7% |
| Nov 2021 | Dec 2021 | 2 | 3.2% | -32.7% | -53.3% |
| Dec 2021 | Dec 2025 | 207 | 70.6% | -52.9% | -51.8% |
| Average | 33 | — | +-17.5% | — |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02